| scholarly article | Q13442814 |
| P2093 | author name string | B A Garvy | |
| C Pomeroy | |||
| S Humphreys | |||
| M H Qureshi | |||
| O R Oakley | |||
| P2860 | cites work | Interleukin-10 and the interleukin-10 receptor | Q24290912 |
| Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 | Q24540441 | ||
| IL-10 inhibits cytokine production by activated macrophages | Q29619453 | ||
| Tumor necrosis factor alpha-mediated toxic shock in Trypanosoma cruzi-infected interleukin 10-deficient mice | Q33597343 | ||
| Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity | Q33693878 | ||
| Cytokines as targets of immunotherapy in bacterial pneumonia. | Q33850654 | ||
| Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands | Q33930607 | ||
| Cytomegalovirus exploits IL-10-mediated immune regulation in the salivary glands | Q36229323 | ||
| Interleukin 10 protects mice from lethal endotoxemia | Q36361558 | ||
| Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration | Q36365733 | ||
| Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. | Q36369341 | ||
| Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection | Q36377083 | ||
| Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) | Q37113833 | ||
| Interleukin-4 and interleukin-10 are involved in host resistance to Staphylococcus aureus infection through regulation of gamma interferon. | Q39515388 | ||
| Interleukin-10 protects neonatal mice from lethal group B streptococcal infection. | Q39825532 | ||
| The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. | Q39868718 | ||
| Interleukin-10 gene knock-out mice: a model of chronic inflammation. | Q40411019 | ||
| Properties and functions of interleukin-10. | Q40696077 | ||
| Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. | Q40951265 | ||
| Cytomegalovirus infection in transplant recipients. The role of tumor necrosis factor. | Q41441513 | ||
| Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings | Q41719407 | ||
| Hierarchical and redundant lymphocyte subset control precludes cytomegalovirus replication during latent infection | Q42971842 | ||
| The role of tumor necrosis factor-alpha in acute murine cytomegalovirus infection in BALB/c mice | Q43725302 | ||
| Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus | Q45735893 | ||
| Characterization of virus-induced interferon-gamma responses in mice previously infected with murine cytomegalovirus | Q45738686 | ||
| The role of IL-10 in mouse hepatitis virus-induced demyelinating encephalomyelitis. | Q45755398 | ||
| Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. | Q45780804 | ||
| IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. | Q46856008 | ||
| Role of interferon-gamma in murine cytomegalovirus infection | Q47671455 | ||
| Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. | Q52009673 | ||
| In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha | Q57339973 | ||
| Elevated Serum Cytokines Are Associated with Cytomegalovirus Infection and Disease in Bone Marrow Transplant Recipients | Q57661240 | ||
| IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi | Q58843169 | ||
| Purification and further characterization of an anti-murine interferon-gamma monoclonal neutralizing antibody | Q70322866 | ||
| An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections | Q70890745 | ||
| Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection | Q71120565 | ||
| Interleukin-10 impairs host defense in murine pneumococcal pneumonia | Q71735371 | ||
| Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia | Q71870349 | ||
| Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor | Q71961272 | ||
| Cytomegalovirus replication in murine microglial cell cultures: suppression of permissive infection by interferon-gamma | Q72388985 | ||
| Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia | Q72416071 | ||
| Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice | Q73082077 | ||
| The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40 | Q73146276 | ||
| IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice | Q73251130 | ||
| The role of the tumor necrosis factor system and interleukin-10 during cytomegalovirus infection in renal transplant recipients | Q73297379 | ||
| The roles of tumour necrosis factor-alpha, interleukin-1 and interleukin-12 in murine cytomegalovirus infection | Q73468006 | ||
| Evidence of active cytomegalovirus infection and increased production of IL-6 in tissue specimens obtained from patients with inflammatory bowel diseases | Q73491451 | ||
| IL-10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii | Q73755946 | ||
| The role of cytokines in the catabolic consequences of infection and injury | Q74545752 | ||
| Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection | Q74638482 | ||
| Factors influencing the effects of murine cytomegalovirus on the pancreas | Q77190558 | ||
| Interleukin-10: potential benefits and possible risks in clinical infectious diseases | Q77735537 | ||
| Treatment of experimental viral myocarditis with interleukin-10 | Q78224532 | ||
| P433 | issue | 1 | |
| P921 | main subject | Cytomegalovirus | Q6946 |
| P304 | page(s) | 155-164 | |
| P577 | publication date | 2007-11-14 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Increased weight loss with reduced viral replication in interleukin-10 knock-out mice infected with murine cytomegalovirus | |
| P478 | volume | 151 |
| Q37377451 | Activating receptors promote NK cell expansion for maintenance, IL-10 production, and CD8 T cell regulation during viral infection |
| Q39051489 | Chronic infections with viruses or parasites: breaking bad to make good |
| Q61807009 | Cytokine-Mediated Induction and Regulation of Tissue Damage During Cytomegalovirus Infection |
| Q36214992 | Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence |
| Q27013680 | Herpesvirus exploitation of host immune inhibitory pathways |
| Q34374800 | IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection |
| Q33927028 | IL-10 production by CD4+ effector T cells: a mechanism for self-regulation |
| Q38445112 | IL-10 restricts activation-induced death of NK cells during acute murine cytomegalovirus infection |
| Q40746828 | IL-10 restricts memory T cell inflation during cytomegalovirus infection |
| Q34372333 | IL-10 suppression of NK/DC crosstalk leads to poor priming of MCMV-specific CD4 T cells and prolonged MCMV persistence. |
| Q35637826 | Immunoregulatory cytokine networks: 60 years of learning from murine cytomegalovirus |
| Q54210009 | Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection. |
| Q34565123 | Interleukin-10 repletion suppresses pro-inflammatory cytokines and decreases liver pathology without altering viral replication in murine cytomegalovirus (MCMV)-infected IL-10 knockout mice |
| Q91708029 | Natural Killer Cell-Derived IL-10 Prevents Liver Damage During Sustained Murine Cytomegalovirus Infection |
| Q37409360 | Nonredundant roles for B cell-derived IL-10 in immune counter-regulation |
| Q28581117 | Periovulatory leukocyte infiltration in the rat ovary |
| Q57930420 | Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies |
| Q33925866 | Reduced lymphocyte infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice |
| Q21131215 | Regulation of adaptive immunity; the role of interleukin-10 |
| Q33797827 | Salivary gland NK cells are phenotypically and functionally unique |
| Q47103806 | Suppression of interleukin-6 increases enterovirus A71 lethality in mice |
| Q38940024 | The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis |
| Q36380567 | The role of IL-10 in regulating immunity to persistent viral infections |
| Q43523896 | The role of decay accelerating factor in the immunopathogenesis of cytomegalovirus infection |
| Q44459161 | The soluble tachyzoite antigen of Toxoplasma gondii has a protective effect on mouse allografts |
Search more.